That is the abbreviated title of a new commentary on the Forbes blog that I wrote with Tomas Philipson. The full article is HERE. An excerpt is below.
New value frameworks in health care have emerged due to increasing cost pressures. Although value frameworks can be useful tools, they should be used to complement the patient-physician treatment decision-making process, rather than substitute for it. This entails getting away from “one size fits all” rules as well as including all treatment aspects that matter to patients. This will resolve the stark difference between many valuation frameworks that deem treatments to be low value and patients who are willing to go bankrupt to access them.
Check out the whole piece HERE.